Neuralstem Inc Real Estate

All Time Past 24 Hours Past Week Past month

Listing Results Neuralstem inc real estate

CUR Neuralstem Stock Price Barchart.com

2 hours ago Barchart.com Show details

Neuralstem Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

Category: Real Estate PriceShow more

Neuralstem Inc Share Price CUR ADVFN InvestorsHub

7 hours ago Ih.advfn.com Show details

Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three primary assets: NSI-189 small molecule program

Category: Real Estate Investor, Real Estate PriceShow more

CUR Stock Forecast, Price & News (Neuralstem) MarketBeat

5 hours ago Marketbeat.com Show details

Neuralstem, Inc. (NASDAQ:CUR) announced its quarterly earnings results on Wednesday, August, 14th. The company reported ($1.45) earnings per share (EPS) for the quarter. The firm had revenue of $0.01 million for the quarter. Neuralstem had a negative trailing twelve-month return on equity of 170.51% and a negative net margin of 39,417.64%.

Rating: 3.3/5
Employees: 6
Phone: 3013664841

Category: Real Estate Market, Real Estate Market Forecast, New Real Estate, Real Estate PriceShow more

NEURALSTEM, INC. : Stock Price US64127R4011 MarketScreener

7 hours ago Marketscreener.com Show details

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of

Category: Real Estate Market, Real Estate Price, Real Estate MarketsShow more

Neuralstem Stock Forecast: down to 1.899 USD? CUR Stock

2 hours ago Walletinvestor.com Show details

021-10-11Neuralstem, Inc. real time quote is equal to 2.390 USD at 2021-10-11, but your current investment may be devalued in the future. Get Our PREMIUM Forecast Now, from ONLY $8.49! - Try Now Risk-Free - Money-back guarantee!

Category: Real Estate Market ForecastShow more

CUR Neuralstem Stock Profile Barchart.com

Just Now Barchart.com Show details

Company profile for Neuralstem Inc (CUR) including business summary, key statistics, ratios, sector. Today's Price Surprises New Highs & Lows Performance Price Change Funds Screener. Options. Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. Volume reflects consolidated markets. Futures and Forex: 10 or 15 minute delay, CT.

Category: Real EstateShow more

Neuralstem, Inc. (CUR): Updated Phase II Trial Success in

8 hours ago Finance.yahoo.com Show details

Neuralstem (NASDAQ:CUR) stock is on fire after revealing a huge clinical win that has sent bulls storming the market today to buy into piece of …

Category: Real EstateShow more

Neuralstem gets a new name Washington Business Journal

5 hours ago Bizjournals.com Show details

Neuralstem (NASDAQ: CUR), soon to become Seneca Biopharma on the Nasdaq exchange, reported a net loss of $4.6 million for the first half of the year, compared with a …

Category: New Real Estate, Real Estate Journal, Washington Real EstateShow more

Neuralstem, Inc. (Form: 8K, Received: 10/29/2018 12:26:54)

8 hours ago Content.edgar-online.com Show details

On October 25, 2018, Neuralstem, Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (“Investors”) for the sale by the Company of 3,000,000 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) at a purchase price of $0

Category: Real EstateShow more

CUR Initiating Coverage of Neuralstem, Inc.

4 hours ago Finance.yahoo.com Show details

May 15, 2012, 6:00 AM. By Jason Napodano, CFA. We are initiating coverage of Neuralstem Inc. (NYSE AMEX:CUR) with an ‘Outperform’ rating and $3.00 price target. We believe the company’s dual

Category: Real EstateShow more

NeuralStem Crunchbase Company Profile & Funding

Just Now Crunchbase.com Show details

Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease."

Category: Real Estate CompanyShow more

CUR Stock Price Sociedade das Aguas da Curia S/A Stock

2 hours ago Marketwatch.com Show details

CUR Complete Sociedade das Aguas da Curia S/A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Category: Real Estate PriceShow more

Neuralstem Announces Pricing of $7.5 Million Underwritten

8 hours ago Prnewswire.com Show details

Neuralstem Announces Pricing of $7.5 Million Underwritten Public Offering. GERMANTOWN, Md., July 25, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the "Company") today

Category: Real EstateShow more

Palisade Bio, Inc. (PALI) Stock Price Today, Quote & News

6 hours ago Seekingalpha.com Show details

A high-level overview of Palisade Bio, Inc. (PALI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Category: New Real Estate, Real Estate PriceShow more

CUR Stock Quote of Neuralstem Inc InvestorPlace

5 hours ago Investorplace.com Show details

Check out our CUR stock analysis, current CUR quote, charts, and historical prices for Neuralstem Inc stock

Category: Real Estate InvestorShow more

Some Neuralstem (NASDAQ:CUR) Shareholders Have Copped A 99

Just Now Ca.finance.yahoo.com Show details

While not a mind-blowing move, it is good to see that the Neuralstem, Inc. share price has gained 26% in the last three months. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. Five years have seen the share price descend precipitously, down a full 99%.

Category: Real EstateShow more

Jobs with NeuralStem Inc. BioSpace

7 hours ago Biospace.com Show details

Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the "Company") today announced the closing of its underwritten public offering of an aggregate of 2,777,777 units at a public offering price of $2.70 per unit resulting in gross proceeds of approximately $7,500,000, before deducting discount, commissions and estimated offering expenses.

Category: Real Estate JobsShow more

Google Finance Stock Market Prices, Realtime Quotes

1 hours ago Google.com Show details

Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.

Category: Real Estate Market, Real Estate PriceShow more

CUR Stock Price Today Zacks

7 hours ago Zacks.com Show details

View %COMPANY_NAME% CUR investment & stock information. Get the latest %COMPANY_NAME% CUR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Category: Real Estate PriceShow more

Neuralstem Announces a 1for20 Reverse Stock Split

7 hours ago Prnewswire.com Show details

GERMANTOWN, Md., July 16, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today

Category: Real EstateShow more

CUR: NA Interactive Chart Zacks.com

9 hours ago Zacks.com Show details

Real Estate; Retirement Planning Neuralstem, Inc. -rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any

Category: Real EstateShow more

Germantownbased stem cell therapy company Neuralstem

Just Now Bizjournals.com Show details

In April, Neuralstem officials received a warning of delisting because the company's minimum bid price of common stock was below $1 per share for 30 consecutive business days. Neuralstem (NASDAQ

Category: Real Estate CompanyShow more

Neuralstem Interactive Stock Chart (PALI) Investing.com

1 hours ago Investing.com Show details

Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Category: Real Estate InvestingShow more

Today’s Research Reports on Trending Tickers: Neuralstem

8 hours ago Ca.finance.yahoo.com Show details

Neuralstem's stock jumped 13.77% Tuesday, to close the day at $1.90. The stock recorded a trading volume of 3,126,210 shares, which was above its three months average volume of 200,552 shares. In the last year, Neuralstem's shares have traded in a range of 0.88 - 6.60. The share price has gained 115.91% from its 52 week low.

Category: Real EstateShow more

PALI Stock quote for PALISADE BIO, INC. MSN Money

4 hours ago Msn.com Show details

Adhesion Barrier Market Size to Garner USD 928.78 Million By 2025 at 7.32% CAGR - Report by Market Research Future (MRFR) Yahoo 7/5/2021

Category: Real EstateShow more

SEC Charges Couple With Insider Trading on Confidential

6 hours ago Its.markets Show details

According to the complaint, after the negative news was announced the next morning, the price of Neuralstem stock dropped by approximately 50%. As alleged, by selling their stock in advance of the news, Calice avoided losses of $103,875 and his uncle avoided losses of $14,434.

Category: Real EstateShow more

iWatchMarkets Trending Business Marketing Finance News Here

6 hours ago Iwatchmarkets.com Show details

iWatchMarkets.com provide by Latest Trending News Today, Viral News, Business Marketing Finance Lifestyle Technology and world stock News Here.

Category: Real Estate Marketing Specialist, Real Estate Market, New Real Estate, Real Estate MarketsShow more

citybizlist : Baltimore : Neuralstem Receives $20M

7 hours ago Baltimore.citybizlist.com Show details

GERMANTOWN, Md., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, today announced that on September 7, 2016, it entered into definitive agreements with Tianjin Pharmaceutical Holding Group for the private …

Category: Real EstateShow more

January 13, 2020 – Thailand News Day

9 hours ago Thailandnewsday.com Show details

Thailand’s Public Health Ministry today announced the first case of New Coronavirus Pneumonia in the country, but assured the public that there is no wider outbreak of the virus.Public Health Minister Anuthin Charnvirakul told the media today (Monday) …

Category: New Real Estate, Land For SaleShow more

Neuralstem Worker Tipped Shareholder to Trial Results, SEC

Just Now Bnnbloomberg.ca Show details

Neuralstem changed its name to Seneca Biopharma Inc. in 2019 and merged with Leading BioSciences Inc. in April to become Palisade Bio Inc. The case is Securities and Exchange Commission v. Chad Calice and Holly Hand, 21-cv-5009, U.S. District Court, Southern District of New York (Manhattan). ©2021 Bloomberg L.P.

Category: Real EstateShow more

Securities Industry Commentator by Bill Singer Esq

Just Now Rrbdlaw.com Show details

According to the complaint, after the negative news was announced the next morning, the price of Neuralstem stock dropped by approximately 50%. As alleged, by selling their stock in advance of the news, Calice avoided losses of $103,875 and his uncle avoided losses of $14,434.

Category: Real EstateShow more

Benzinga Stock Market Quotes, Business News, Financial

4 hours ago Benzinga.com Show details

Neuralstem, Inc. (AMEX: CUR) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga.

Category: Real Estate Market, New Real Estate, Financial District RentalsShow more

Clinical Trials Manager Settles SEC Insider Trading Suit

6 hours ago Law360.com Show details

A former Neuralstem Inc. clinical trials manager tipped her partner to bad company news, allowing him to avoid over $103,000 of investment losses, the …

Category: Real EstateShow more

BYSI Company Profile & Executives BeyondSpring Inc

6 hours ago Wsj.com Show details

Real Estate. Sections. Commercial Real Estate; More. President, Chief Executive Officer & CFO by Neuralstem, Inc., a Managing Director by Ravine Rock Partners LLC, an Independent Director by

Category: Real Estate CompanyShow more

Williams Scotsman to Acquire Acton Mobile – Thailand News Day

Just Now Thailandnewsday.com Show details

Truckers threaten strike if diesel prices are not pegged Human resources and inequality, main issues needing serious attention Nakhon Si Thammarat quiet after being declared a COVID-19 “dark red” province

Category: New Real Estate, Land For SaleShow more

Penny Stocks to Buy Biotech Stocks InvestorPlace

2 hours ago Investorplace.com Show details

With shares up +40% since January, CYCC could end up being a bargain at its current price of around $1.45 if it can manage to swing into another uptrend. Luna Innovations Inc

Category: Real Estate InvestorShow more

a_vtgrowthopps.htm

4 hours ago Sec.gov Show details

R Real Estate Investment Trust. S Security on loan, in part or in entirety, at the close of the reporting period (Note 1). At the close of the reporting period, the fund maintained liquid assets totaling $19,849 to cover certain derivative contracts and the settlement of certain securities.

Category: Real EstateShow more

citybizlist : Baltimore : Neuralstem Appoints Ken Carter

8 hours ago Baltimore.citybizlist.com Show details

GERMANTOWN, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, appointed Kenneth C. Carter, Ph.D., as the Company’s Executive Chairman of the Board to be effective on January 1, 2019.

Category: Real EstateShow more

Weekly CFO Buy Highlights: Neu GuruFocus.com

6 hours ago Gurufocus.com Show details

The Dow Jones Industrial Average (DJIA) SP 500 Index Nasdaq Composite Index Gross Domestic Product (GDP) Shiller PE Ratio of Wilshire 5000 over GNP Civilian Unemployment Rate Russell 2000 Small Cap Price Index CBOE Volatility Index (VIX) Total Nonfarm Payrolls: All …

Category: Real EstateShow more

Off to Races with Seven Extraordinary Biotech & Medtech

4 hours ago Streetwisereports.com Show details

Novavax Shares Shoot 65% Higher on Phase 3 COVID-19 Vaccine Trial's 89.3% Effectiveness Source: Streetwise Reports (01/29/2021) Novavax Inc. shares established a new 52-week high after the firm's COVID-19 vaccine demonstrated an 89.3% efficacy rate in a Phase 3 trial in the U.K. and also showed efficacy against the South African variant in a Phase 2b trial.

Category: Real EstateShow more

Hot Stocks: Capital Assets Washingtonian (DC)

7 hours ago Washingtonian.com Show details

Neuralstem (AMEX: NRLS). In a study at the University of California at San Diego, paralyzed rats treated with Neuralstem’s human neural stem cells were able to walk again. The Rockville company’s stem-cell technology was developed by Dr. Karl Johe while he was at the National Institute of Neurological Disorders and Stroke in the late 1990s.

Category: Washington Real EstateShow more

Insider Trading Alert CUR, LLY And GGP Traded By

9 hours ago Thestreet.com Show details

Highlighted Stocks Traded by Insiders: Neuralstem - FREE Research Report. Johe Karl, who is Chief Scientific Officer at Neuralstem, sold 25,000 shares at $1.52 on Sept. 21, 2015.

Category: Real EstateShow more

2021 Acute Spinal Cord Injury Market Size Latest

2 hours ago Marketwatch.com Show details

The Acute Spinal Cord Injury market revenue was Million USD in 2016, grew to Million USD in 2021, and will reach Million USD in 2026, with a CAGR during 2021-2026.

Category: Real Estate MarketShow more

New Post Listing

Frequently Asked Questions

How much money does Neuralstem make a year?

One share of CUR stock can currently be purchased for approximately $3.79. How much money does Neuralstem make? Neuralstem has a market capitalization of $7.96 million and generates $260,000.00 in revenue each year.

Where is the mailing address for Neuralstem?

Neuralstem's mailing address is 20271 Goldenrod Lane, Germantown MD, 20876. The company can be reached via phone at 301-366-4841 or via email at [email protected]

What kind of rating does Neuralstem have on marketbeat?

Wall Street analysts have given Neuralstem a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Neuralstem wasn't one of them.

All Time Past 24 Hours Past Week Past month

Popular Search